Literature DB >> 15319150

Chemokine networks in inflammatory skin diseases.

Saveria Pastore1, Francesca Mascia, Feliciana Mariotti, Cristina Dattilo, Giampiero Girolomoni.   

Abstract

The superfamily of chemokines comprises numerous small, cytokine-like chemotactic proteins, which have a fundamental role in the regulation of leukocyte trafficking. The chemokine-chemokine receptor system is highly redundant and promiscuous, and forms a complex network relevantly involved in the expression of chronic inflammatory skin diseases, including allergic contact dermatitis, atopic dermatitis and psoriasis. The pattern of chemokine expression shows overlapping features but also important differences in these diseases due to distinct sources and types of pro-inflammatory signals involved in chemokine induction, and the inherent capacity of resident skin cells to produce chemokines. Chemokine receptors (G-protein coupled receptors) rather than chemokines appear the appropriate therapeutic targets as they are more chemically tractable and play less redundant functions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15319150

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  13 in total

1.  Tumour necrosis factor-like weak inducer of apoptosis (TWEAK), an important mediator of endothelial inflammation, is associated with the pathogenesis of Henoch-Schonlein purpura.

Authors:  T Chen; Z-P Guo; M-M Li; J-Y Li; X-Y Jiao; Y-H Zhang; H-J Liu
Journal:  Clin Exp Immunol       Date:  2011-07-15       Impact factor: 4.330

2.  The NF-κB regulator Bcl-3 modulates inflammation during contact hypersensitivity reactions in radioresistant cells.

Authors:  Ilaria Tassi; Nimisha Rikhi; Estefania Claudio; Hongshan Wang; Wanhu Tang; Hye-Lin Ha; Sun Saret; Daniel H Kaplan; Ulrich Siebenlist
Journal:  Eur J Immunol       Date:  2015-02-12       Impact factor: 5.532

3.  Microbicidal protein psoriasin is a multifunctional modulator of neutrophil activation.

Authors:  Yan Zheng; François Niyonsaba; Hiroko Ushio; Shigaku Ikeda; Isao Nagaoka; Ko Okumura; Hideoki Ogawa
Journal:  Immunology       Date:  2008-01-08       Impact factor: 7.397

4.  Dendritic cells activated by IFN-γ/STAT1 express IL-31 receptor and release proinflammatory mediators upon IL-31 treatment.

Authors:  Jutta Horejs-Hoeck; Harald Schwarz; Sebastian Lamprecht; Elisabeth Maier; Stefan Hainzl; Maria Schmittner; Gernot Posselt; Angelika Stoecklinger; Thomas Hawranek; Albert Duschl
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

Review 5.  Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation.

Authors:  Ravi Starzl; Gerald Brandacher; W P Andrew Lee; Jaime Carbonell; Wensheng Zhang; Jonas Schnider; Vijay Gorantla; Stefan Schneeberger; Xin Xiao Zheng
Journal:  Clin Dev Immunol       Date:  2013-02-13

6.  ONZIN deficiency attenuates contact hypersensitivity responses in mice.

Authors:  Julie G Ledford; Martina Kovarova; Leigh A Jania; Mytrang Nguyen; Beverly H Koller
Journal:  Immunol Cell Biol       Date:  2012-01-17       Impact factor: 5.126

7.  Impaired Langerhans cell migration in psoriasis.

Authors:  Marie Cumberbatch; Minal Singh; Rebecca J Dearman; Helen S Young; Ian Kimber; Christopher E M Griffiths
Journal:  J Exp Med       Date:  2006-03-27       Impact factor: 14.307

8.  Retinoic Acid promotes interleukin-4 plasmid-dimethylsulfoxide topical transdermal delivery for treatment of psoriasis.

Authors:  Zhong-Wen Chen; Yin-Bing Zhang; Xaing-Jun Chen; Xiao Liu; Zhen Wang; Xi-Kun Zhou; Ji Qiu; Nan-Nan Zhang; Xiu Teng; Yong-Qiu Mao; Chang-Yong Liu; Yu-Quan Wei; Jiong Li
Journal:  Ann Dermatol       Date:  2015-03-24       Impact factor: 1.444

9.  Therapeutic efficacy and immunological response of CCL5 antagonists in models of contact skin reaction.

Authors:  Miriam Canavese; Fiorella Altruda; Lorenzo Silengo
Journal:  PLoS One       Date:  2010-01-15       Impact factor: 3.240

Review 10.  Mechanisms and mediators of inflammation: potential models for skin rejection and targeted therapy in vascularized composite allotransplantation.

Authors:  Theresa Hautz; Dolores Wolfram; Johanna Grahammer; Ravi Starzl; Christoph Krapf; Johann Pratschke; W P Andrew Lee; Gerald Brandacher; Stefan Schneeberger
Journal:  Clin Dev Immunol       Date:  2012-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.